Literature DB >> 1748483

Involvement in lupus disease of idiotypes Id.F-423 and Id.IV-228 defined, respectively, upon foetal and adult MRL/Mp-lpr/lpr DNA-binding monoclonal autoantibodies.

C T Ravirajan1, N A Staines.   

Abstract

The derivation of a monoclonal IgG3K autoantibody, designated F-423, from a foetal MRL/Mp-lpr/lpr mouse is described. It has immunochemical properties similar to DNA-binding monoclonal antibodies derived from adult mice with lupus disease in that it reacts with single-stranded DNA and, to a lesser extent, with double-stranded DNA and some forms of RNA. Its similarities to antibodies from adults extend further: it carries a public idiotype, Id.F-423, that can also be detected on antibodies from adult MRL and (NZB x NZW)F1 mice, and F-423 itself expresses other idiotypes defined originally on antibodies from adult lupus mice of both strains. Its potential involvement in pathological processes is demonstrated by two observations: (i) immunization of young MRL/Mp-+/+ mice with antibody F-423 induced the nephritic and immunological changes associated with systemic lupus erythematosus; and (ii) heterologous rabbit anti-Id.F-423 anti-idiotypic antibodies suppressed the progression of lupus disease in adult MRL/Mp-lpr/lpr mice. Similar effects were found with monoclonal antibody IV-228, an antibody derived from an adult MRL mouse and previously known to be directly nephrotoxic, and with anti-Id.IV-228 antibodies. It is concluded that even during foetal life mice of lupus-prone strains have lymphocytes capable of making pathogenic autoantibodies long before symptoms of lupus disease appear.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1748483      PMCID: PMC1384616     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  19 in total

1.  Five groups of antigenic determinants on DNA identified by monoclonal antibodies from (NZB X NZW)F1 and MRL/Mp-lpr/lpr mice.

Authors:  A Morgan; R R Buchanan; A M Lew; I Olsen; N A Staines
Journal:  Immunology       Date:  1985-05       Impact factor: 7.397

2.  Functional characterization of monoclonal auto-anti-idiotype antibodies isolated from the early B cell repertoire of BALB/c mice.

Authors:  M Vakil; J F Kearney
Journal:  Eur J Immunol       Date:  1986-09       Impact factor: 5.532

3.  Comparison of DNA antibody idiotypes in human sera: an international collaborative study of 19 idiotypes from 11 different laboratories.

Authors:  D Isenberg; W Williams; J Axford; R Bakimer; D Bell; T Casaseca-Grayson; B Diamond; F Ebling; B Hahn; G Harkiss
Journal:  J Autoimmun       Date:  1990-08       Impact factor: 7.094

4.  A monoclonal DNA-binding autoantibody causes a deterioration in renal function in MRL mice with lupus disease.

Authors:  R A Lake; N A Staines
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

Review 5.  DNA antibody idiotypes: an analysis of their clinical connections and origins.

Authors:  R Watts; D Isenberg
Journal:  Int Rev Immunol       Date:  1990       Impact factor: 5.311

6.  Murine monoclonal anti-DNA antibodies bind directly to glomerular antigens and form immune deposits.

Authors:  M P Madaio; J Carlson; J Cataldo; A Ucci; P Migliorini; O Pankewycz
Journal:  J Immunol       Date:  1987-05-01       Impact factor: 5.422

7.  DNA-binding antibodies and parasitic diseases.

Authors:  A O Wozencraft; N A Staines
Journal:  Parasitol Today       Date:  1990-08

8.  Suppression of anti-DNA antibody production in MRL mice by treatment with anti-idiotypic antibodies.

Authors:  W Mahana; B Guilbert; S Avrameas
Journal:  Clin Exp Immunol       Date:  1987-12       Impact factor: 4.330

9.  Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype.

Authors:  S Mendlovic; S Brocke; Y Shoenfeld; M Ben-Bassat; A Meshorer; R Bakimer; E Mozes
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

10.  Detection of human and murine common idiotypes of DNA antibodies in tissues and sera of patients with autoimmune diseases.

Authors:  R A Watts; C T Ravirajan; L S Wilkinson; W Williams; M Griffiths; D Butcher; A T Horsfall; N A Staines; D A Isenberg
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

View more
  6 in total

1.  Idiotype usage by polyclonally activated B cells in experimental autoimmunity and infection.

Authors:  M Sutmuller; J J Baelde; M P Madaio; J A Bruijn; E De Heer
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

2.  Natural antibodies that react with V-region peptide epitopes of DNA-binding antibodies are made by mice with systemic lupus erythematosus as disease develops.

Authors:  F J Ward; J E Knies; C Cunningham; W J Harris; N A Staines
Journal:  Immunology       Date:  1997-11       Impact factor: 7.397

3.  Molecular cloning of metaphase chromosome protein 1 (MCP1), a novel human autoantigen that associates with condensed chromosomes during mitosis.

Authors:  E Bronze-da-Rocha; J A Catita; C E Sunkel
Journal:  Chromosome Res       Date:  1998-02       Impact factor: 5.239

4.  Primary sequence and location of the idiotopes of V-88, a DNA-binding monoclonal autoantibody, determined by idiotope scanning with synthetic peptides on pins.

Authors:  N A Staines; F J Ward; A N Denbury; J Mitchiner; O Hartley; D Eilat; D A Isenberg; S Bansal
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

5.  Characterization and pathological significance of monoclonal DNA-binding antibodies from mice with experimental malaria infection.

Authors:  C M Lloyd; I Collins; A J Belcher; N Manuelpillai; A O Wozencraft; N A Staines
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

6.  Systemic lupus erythematosus murine monoclonal DNA-binding antibodies recognize cytoplasmic and nuclear phosphorylated antigens that display cell cycle redistribution in HEp-2 cells.

Authors:  E Bronze-da-Rocha; C Machado; N A Staines; C E Sunkel
Journal:  Immunology       Date:  1992-12       Impact factor: 7.397

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.